tiprankstipranks
Trending News
More News >
NovoCure Ltd (NVCR)
NASDAQ:NVCR

NovoCure (NVCR) Revenue

Compare
1,492 Followers

NovoCure Revenue

NovoCure had a revenue of 154.99M in the quarter ending Mar 31, 2025, with -3.89%. This bring the company's revenue in the last twelve months to 621.71M, Decreased 2.72%. In the fiscal year ending Dec 31, 2024, NovoCure had annual revenue of 605.22M with 18.82% growth.
Revenue (ttm)
621.71M
Revenue Growth
18.27%
P/S Ratio
3.34
Revenue/Employee
$406,734
Employees
1,488
Market Cap
$2.02B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024605.22M95.88M+18.82%
Dec 31, 2023509.34M-28.50M-5.30%
Dec 31, 2022537.84M2.81M+0.53%
Dec 31, 2021535.03M40.66M+8.23%
Dec 31, 2020494.37M143.05M+40.72%
Dec 31, 2019351.32M103.25M+41.62%
Dec 31, 2018248.07M71.04M+40.13%
Dec 31, 2017177.03M94.14M+113.57%
Dec 31, 201682.89M49.80M+150.52%
Dec 31, 201533.09M17.60M+113.60%
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis